Samuel L. Washington III, MD, MAS

Samuel L. Washington III, MD, MAS

Goldberg-Benioff Endowed Professorship in Cancer Biology, UCSF

Assistant Professor of Urology; Epidemiology & Biostatistics; Community Engagement Liaison, Prostate Cancer Program, Helen Diller Family Comprehensive Cancer Center; Associate Chair of Diversity, Equity, and Inclusion; Department of Urology, UCSF

Cancer Center Program Membership

Prostate Cancer

Phone: (415) 476-4616 (appts)

Box 1695, UCSF
San Francisco, CA 94143

Physician Biography

UCSF Profiles

Research Summary

Dr. Washington's research efforts focus on outcomes research for patients with genitourinary cancers, with an emphasis on identifying systems-level and region-specific targets for intervention to improve access to care and reduce healthcare disparities for individuals with genitourinary cancers including prostate cancer and bladder cancer.

Research Funding

  • October 30, 2024 - October 30, 2027 - Multilevel assessment of social needs and partnering with community stakeholders to prospectively address local barriers to prostate cancer care , Principal Investigator . Sponsor: Prostate Cancer Foundation, Sponsor Award ID:
  • September 1, 2024 - August 30, 2026 - Generating and evaluating interventions to drive health equity in Prostate Cancer care , Principal Investigator . Sponsor: The Movember Foundation, Sponsor Award ID:
  • May 31, 2024 - June 30, 2025 - Local assessment of interest and engagement of Black men for interventions to address barriers to prostate cancer care , Principal Investigator . Sponsor: UCSF Helen Diller Family Comprehensive Cancer Center Community-Engaged Research Pilot Project Award, Sponsor Award ID:
  • December 2, 2021 - November 30, 2024 - An Atlas of Human Prostate AcrossAncestries to develop a comprehensive atlas of the human pros-tate at single-cell resolution with a community engagement plan to maximize impact for the public and clinical and scientific communities , Co-Principal Investigator . Sponsor: Chan Zuckerberg Initiative DAF, Sponsor Award ID: P0559192
  • January 1, 2023 - May 30, 2024 - Understanding association between social risk and guideline concordant treatment for clinically localized prostate cancer , Principal Investigator . Sponsor: UCSF Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program, Sponsor Award ID:
  • December 1, 2021 - November 30, 2022 - Drivers of racial disparities in management of advanced prostate cancer: examining local and geo-graphic variations in evaluation and treatment. , Principal Investigator . Sponsor: ConcertAI, Sponsor Award ID:
  • October 1, 2019 - October 1, 2020 - Impact of socioeconomic status on overutilization of healthcare expenditure in patients with bladder cancer , Co-Investigator . Sponsor: OptumLabs, Sponsor Award ID: 20183
  • July 1, 2018 - June 30, 2019 - The Differential Impact of Race on Oncologic Outcomes in Elderly Patients with Bladder Cancer: A Population-based Study , Co-Principal Investigator . Sponsor: NIA RCMAR/UCSF Center for Aging in Diverse Communities Scholars Program, Sponsor Award ID: 132016C
  • July 1, 2017 - June 30, 2018 - The Interventions to Reduce Resident Exhaustion and Depersonalization , Co-Principal Investigator . Sponsor: UCSF Academy of Medical EducatorsUCSF, Sponsor Award ID: 1000112
  • - - Biomechanical computed tomography facilitates the diagnosis of osteoporosis and fracture prediction in patients with high risk prostate cancer , Co-Investigator . Sponsor: US Department of Defense, Sponsor Award ID: W81XWH-21-PCRP-DSA

Education

  • University of California, Davis, BS, 2007, Genetics
  • University of California, San Francisco, MD, 2012
  • University of California, San Francisco, MOTH, 2019, Masters of Advanced Study in Clinical Research
  • University of California, San Francisco, Resident, 2018, Urology
  • University of California, San Francisco, Postdoctoral Fellow, 2020, Urologic Oncology
  • University of California, San Francisco, UCSF Health Executive Leadership Academy, August 2023-June 2024
  • University of California, San Francisco, Foundations for Excellence in Leadership Program, May 2024 - Present

Honors & Awards

  • 2024
    Western Section American Urological Association. Second Place, Joseph F. McCarthy Physician Essay Contest
  • 2023
    Western Section American Urological Association. First place Poster Session
  • 2021 - 2022
    Engaging Research to Achieve Cancer Care Equity (ERACE) Research Award, ConcertAI
  • 2021
    Goldberg-Benioff Endowed Professorship in Cancer Biology, University of California, San Francisco
  • 2021
    Grunfeld Scholar, San Francisco VA Healthcare System Research Development Initiative
  • 2021
    John A. Watson Faculty Scholar, Dean's Diversity Fund, University of California, San Francisco
  • 2019 - 2020
    OptumLabs Health Data for Action: Leveraging Health Data for Actionable Insights Data Access Award, OptumLabs
  • 2018 - 2019
    UCSF CADC Scholar, UCSF Center for Aging in Diverse Communities
  • 2010 - 2011
    Pathways to Careers in Clinical and Translational Research Yearlong Fellowship, University of California, San Francisco
  • 2009 - 2009
    Dean's Summer Research Fellowship, University of California, San Francisco

Selected Publications

  1. Washington, SL III, Cooperberg, MR. Prostate Cancer: Clinical Case Scenarios. Active Surveillance in African-Americans.  View on PubMed
  2. Carlisle MN, Li KD, Jarosek SL, Faris AR, Patel HV, Washington SL, Breyer BN. Rural-Urban Differences and Socioeconomic Disparities in Long-Term Urinary Adverse Events Following Prostate Cancer Treatment. Urol Pract. 2025 May 27; 101097UPJ0000000000000837.  View on PubMed
  3. Shee K, Cowan JE, Ding CC, Wang L, Pace W, Greenland N, Simko JP, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort. Eur Urol Focus. 2025 May 14.  View on PubMed
  4. Palmer NR, Carroll PR, Washington SL. Time is on our side - rethinking the concept of time to treatment for prostate cancer. Nat Rev Urol. 2025 May; 22(5):251-252.  View on PubMed
  5. Ogunsanya ME, Kaninjing E, DeForge SM, Morton DJ, Cole P, Beckford P, Reese D, Mitchell T, Montgomery E, Odeleye R, Miró-Rivera EY, Roberts K, Neil JM, Alexander AC, Funk-Lawler RK, Azizoddin D, Roach M, Washington SL, Dwyer K, Young ME, Odedina FT, Kendzor DE. Bridging the Gap: Enhancing Prostate Cancer Survivorship and Advocacy Among Ethnically Diverse Black Men Through Community Town Halls. J Cancer Educ. 2025 Feb 24.  View on PubMed
  6. Kyaw TS, De La Cueva C, Leva N, Goldberg D, Allen IE, Overland M, Washington S, Copp HL. Disparities in Urine Testing Among Febrile Children in US Emergency Departments. J Racial Ethn Health Disparities. 2025 Feb 17.  View on PubMed
  7. Scheuner MT, Hoggatt KJ, Sales P, Lerner B, Ferino E, Danowski M, Zhang N, Purmal C, Washington SL, Goodman MM, Ziegler EE, Stoddard AJ, Menendez C, Foote T, Rowe K, McWhirter G, Kelley MJ. Mainstreaming improved adoption of germline testing for Veterans Affairs patients with metastatic prostate cancer without exacerbating disparities. Genet Med. 2025 Feb 13; 101383.  View on PubMed
  8. Van Blarigan EL, McKinley MA, Washington SL, Cooperberg MR, Kenfield SA, Cheng I, Gomez SL. Trends in Prostate Cancer Incidence and Mortality Rates. JAMA Netw Open. 2025 Jan 02; 8(1):e2456825.  View on PubMed
  9. Washington Iii SL, Fakunle M, Wang L, Braun AE, Leapman M, Cowan JE, Cooperberg MR. County-level racial disparities in prostate cancer-specific mortality from 2005 to 2020. JNCI Cancer Spectr. 2024 Nov 01; 8(6).  View on PubMed
  10. Oh WK, Agarwal N, Bryce A, Barata P, Bugler C, Carlsson SV, Cornell B, Dahut W, George D, Loeb S, Montgomery B, Morris D, Mucci LA, Omlin A, Palapattu G, Riaz IB, Ryan C, Schoen MW, Washington SL, Gillessen S. What's in a Name? Why Words Matter in Advanced Prostate Cancer. Eur Urol. 2025 Feb; 87(2):101-103.  View on PubMed
  11. Fakunle MO, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Carroll PR. Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2025 Jan; 213(1):34-39.  View on PubMed
  12. Shee K, Nie J, Cowan JE, Wang L, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance. Eur Urol Oncol. 2025 Apr; 8(2):380-386.  View on PubMed
  13. Washington SL, Lonergan PE, Odisho AY, Meng MV, Porten SP. Association of household net worth with healthcare costs after radical cystectomy using real-world data. Cancer Med. 2024 Apr; 13(7):e7116.  View on PubMed
  14. Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell JE, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N. Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer. Health Educ Behav. 2024 06; 51(3):359-366.  View on PubMed
  15. Appleton A, Black K, Sellke NC, Washington SL, Does S, Rhodes S, Downs TM, Saigal C, Vince RA, Ghanney Simons EC. The Future State of Race/Ethnicity in Urology: Urology Workforce Projection From 2021-2061. Urology. 2024 05; 187:39-45.  View on PubMed
  16. Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell J, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N. Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer. J Urol. 2024 Mar; 211(3):376-383.  View on PubMed
  17. Smani S, Novosel M, Sutherland R, Jeong F, Jalfon M, Marks V, Rajwa P, Nolazco JI, Washington SL, Renzulli JF, Sprenkle P, Kim IY, Leapman MS. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. Urol Oncol. 2024 02; 42(2):28.e9-28.e20.  View on PubMed
  18. Andemeskel G, Palmer NR, Pasick R, Van Blarigan EL, Kenfield SA, Graff RE, Shaw M, Yu W, Sanchez M, Hernandez R, Washington SL, Shariff-Marco S, Rhoads KF, Chan JM. Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES). Res Involv Engagem. 2023 Dec 11; 9(1):117.  View on PubMed
  19. Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2024 Aug; 7(4):838-843.  View on PubMed
  20. Khajir G, Press B, Lokeshwar S, Ghabili K, Rahman S, Gardezi M, Washington S, Cooperberg MR, Sprenkle P, Leapman MS. Prostate cancer risk stratification using magnetic resonance imaging-ultrasound fusion vs systematic prostate biopsy. JNCI Cancer Spectr. 2023 10 31; 7(6).  View on PubMed

Go to UCSF Profiles, powered by CTSI